Bank of the West’s Idexx Laboratories IDXX Stock Holding History

Bank of the West’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-680	Closed	-$267K	–	217
2020 Q3	$267K	Hold	680	–	–	0.04%	190
2020 Q2	$225K	Buy	+680	New	+$197K	0.03%	224

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Bank of the West's IDXX Position: Q4 2020 in Review

Bank of the West sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 680 shares — an estimated $267K sold.

Bank of the West first reported a position in IDXX in Q2 2020 and held it in 2 quarters. The position peaked at $267K in Q3 2020. 972 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

Bank of the West reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
Bank of the West sold 680 Idexx Laboratories shares in Q4 2020, an estimated $267K.
Bank of the West first reported a position in Idexx Laboratories in Q2 2020 and held it in 2 quarters.
Bank of the West's Idexx Laboratories position peaked at $267K in Q3 2020.
972 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Bank of the West's 13F filing for Q4 2020, filed 2 Feb 2021.